Hugh O'Brien

Hugh O'Brien currently serves as the Chief Technology Officer at Lir Therapeutics, a position held since October 2024. Prior to this role, Hugh O'Brien was involved with Achilles Therapeutics plc as a Senior AI Research Scientist and Senior Bioinformatics Scientist from January 2022 to November 2024. A software developer at Overleaf (Writelatex Limited) from September 2016 to November 2021, Hugh O'Brien also held positions as an Editorial Consultant and Senior Publications Assistant at the Public Library of Science between August 2013 and January 2016. Educational qualifications include a PhD in Biomedical/Medical Engineering and an MRes in Imaging Sciences from King's College London, as well as an MSc in Computer Science from Imperial College London and a BA in Psychology from Trinity College Dublin.